HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 80 filers reported holding HARVARD BIOSCIENCE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,813 | -21.5% | 14,375 | +0.2% | 0.01% | -22.2% |
| Q2 2023 | $78,727 | +30.7% | 14,340 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $60,228 | +51.6% | 14,340 | 0.0% | 0.01% | +50.0% |
| Q4 2022 | $39,722 | +7.4% | 14,340 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $37,000 | -73.8% | 14,340 | -63.5% | 0.01% | -75.7% |
| Q2 2022 | $141,000 | -40.8% | 39,300 | +2.6% | 0.04% | -27.5% |
| Q1 2022 | $238,000 | -11.9% | 38,300 | 0.0% | 0.05% | -12.1% |
| Q4 2021 | $270,000 | +1.1% | 38,300 | 0.0% | 0.06% | +9.4% |
| Q3 2021 | $267,000 | -16.3% | 38,300 | 0.0% | 0.05% | -28.4% |
| Q2 2021 | $319,000 | – | 38,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 3,542,852 | $10,536,000 | 4.92% |
| Fondren Management LP | 865,000 | $2,660,000 | 2.21% |
| Harvey Partners, LLC | 742,500 | $2,283,000 | 1.65% |
| BARD ASSOCIATES INC | 311,922 | $959,000 | 0.49% |
| Adirondack Research & Management Inc. | 131,042 | $403,000 | 0.35% |
| Granahan Investment Management | 1,771,964 | $5,449,000 | 0.30% |
| DALTON GREINER HARTMAN MAHER & CO | 1,373,518 | $4,224,000 | 0.29% |
| HEARTLAND ADVISORS INC | 1,000,000 | $3,075,000 | 0.24% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 499,616 | $1,536,000 | 0.22% |
| Alambic Investment Management, L.P. | 43,569 | $134,000 | 0.10% |